Ahram Biosystems Overview

  • Founded
  • 2001

Founded
  • Status
  • Private

  • Employees
  • 10

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.34M

  • Investors
  • 4

Ahram Biosystems General Information

Description

Developer of life science tools intended to bring portable innovation to the biotechnology market. The company leverages technology to develop products including new life science tools, PCR devices and cell-based assay systems, enabling clients to target molecular diagnostics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
  • 1203 Youngdong Technotower
  • 300-4 Sungsu-dong 2-ga
  • Seoul, 04794
  • South Korea
+82 00-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ahram Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 10-Mar-2017 $4.34M 00.000 Completed Generating Revenue
1. Later Stage VC 20-Mar-2015 00.000 00.000 Completed Generating Revenue
To view Ahram Biosystems’s complete valuation and funding history, request access »

Ahram Biosystems Patents

Ahram Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2003269522-A1 Target detection system having a conformationally sensitive probe comprising a nucleic acid based signal transducer Abandoned 11-Oct-2002 0000000000
JP-2006513701-A Target detection system having a conformationally sensitive probe including a nucleic acid based signal transducer Granted 11-Oct-2002 0000000000 0
JP-2010099090-A Target detection system having conformationally sensitive probe comprising nucleic acid based signal transducer Abandoned 11-Oct-2002 0000000000
US-20050118603-A1 Using nucleic acid based signal transducer that reports association of the target agent and probe by shifting from one hybridization state to another in a detectable manner; gene expression analysis Abandoned 11-Oct-2002 0000000000 00
EP-1558626-A1 Target detection system having a conformationally sensitive probe comprising a nucleic acid based signal transducer Withdrawn 11-Oct-2002 C12Q1/6825 0
To view Ahram Biosystems’s complete patent history, request access »

Ahram Biosystems Executive Team (2)

Name Title Board Seat Contact Info
Hyun Hwang Founder, Chief Executive Officer, President and Chairman
Jane Kim Chief Scientific Officer & Vice President, Business Development
To view Ahram Biosystems’s complete executive team members history, request access »

Ahram Biosystems Board Members (1)

Name Representing Role Since
Hyun Hwang Ahram Biosystems Founder, Chief Executive Officer, President and Chairman 000 0000
To view Ahram Biosystems’s complete board members history, request access »

Ahram Biosystems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ahram Biosystems Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
DAOL Investment PE/Buyout Minority 000 0000 000000 0
Mega Investment Corporate Venture Capital Minority 000 0000 000000 0
Timewise Investments Venture Capital Minority 000 0000 000000 0
SV Investment Venture Capital Minority 000 0000 000000 0
To view Ahram Biosystems’s complete investors history, request access »